Armistice Capital, LLC Prothena Corp Public LTD CO Transaction History
Armistice Capital, LLC
- $7.08 Billion
- Q4 2024
A detailed history of Armistice Capital, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Armistice Capital, LLC holds 2,236,000 shares of PRTA stock, worth $29.8 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
2,236,000
Previous 1,650,000
35.52%
Holding current value
$29.8 Million
Previous $27.6 Million
12.19%
% of portfolio
0.44%
Previous 0.46%
Shares
5 transactions
Others Institutions Holding PRTA
# of Institutions
197Shares Held
39.3MCall Options Held
601KPut Options Held
259K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$155 Million7.5% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$51.5 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.69MShares$49.2 Million0.01% of portfolio
-
State Street Corp Boston, MA1.86MShares$24.8 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.74MShares$23.2 Million3.85% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $626M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...